This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...
Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher incidence of prostate cancer and are more likely to die from it than are ...
September 12, 2012 — The US Food and Drug Administration (FDA) today approved the production and use of a new positron emission tomography (PET) imaging agent, Choline C 11 Injection, which will be ...
CLEVELAND, Ohio — A recent study led by Cleveland-area researchers suggests that prostate cancers classified as low risk may not be as low risk as previously thought. The study included researchers ...